| Trademark Snap Shot Amendment to Delete or Correct Basis (Table presents the data on Amendment to Delete or Correct Basis) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88604262 | FILING DATE | 09/04/2019 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | FIONDA, LAURA ELIZABET |
L.O. ASSIGNED | 108 |
PUB INFORMATION |
|||
| RUN DATE | 01/18/2020 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 01/17/2020 | ||
| LITERAL MARK ELEMENT | ABYLIAN | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | NO | 1 (b) | NO | 1 (b) | NO |
| 44D | YES | 44D | NO | 44D | NO |
| 44E | YES | 44E | YES | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | ABYLIAN |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Synthon Biopharmaceuticals B.V. |
| ADDRESS | Microweg 22 CM Nijmegen, 6545 |
| ENTITY | 16-LTD LIAB CO |
| CITIZENSHIP | Netherlands |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations, substances and compositions, namely, medical diagnostic reagents in the nature of antibody-drug conjugates, immuno-oncology compounds in the nature of medicinal preparations for the treatment of infectious diseases and for use in oncology, and compounds for auto-immune diseases, namely, pharmaceutical preparations for the treatment of immune system related diseases and disorders; Biological and biochemical drugs and cultures for medical use, namely, biological preparations for the treatment of cancer, cultures of microorganisms for medical use, and biological tissue cultures for medical purposes; Pharmaceutical active substances, namely, drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical components and ingredients, namely, drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals |
| INTERNATIONAL CLASS | 010 |
| DESCRIPTION TEXT | Surgical and medical devices, apparatus and instruments, namely, surgical instruments and apparatus, surgical devices and instruments, surgical apparatus and instruments, medical instruments for cutting tissue, and medical instrument for performing biopsies, medical fluid injectors, injection devices for pharmaceuticals, syringes for medical purposes, disposable syringes for medical purposes; Orthopedic articles, namely, orthopedic walkers, orthopedic supports, orthopedic braces and orthopedic cushions; injection apparatus for medical purposes, namely, injection needles and injection instruments with needles |
| INTERNATIONAL CLASS | 035 |
| DESCRIPTION TEXT | Providing office functions relating to the registration of pharmaceutical preparations and components and pharmaceutical drugs; Providing office functions relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; Mediation of trade business for third parties, namely, business mediation in the purchase, sale and licensing of pharmaceutical registrations and pharmaceutical registration files |
| INTERNATIONAL CLASS | 040 |
| DESCRIPTION TEXT | Treatment of materials, including on request, for others, for the purpose of manufacturing pharmaceutical and biopharmaceutical preparations; Manufacture, for others, of pharmaceutical and biopharmaceutical preparations and raw materials for the pharmaceutical industry |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Scientific and technological services and research relating thereto, namely, scientific research, analysis and testing in the fields of antibody-drug conjugates, immuno-oncology compounds and compounds for auto-immune diseases and scientific research related thereto; Scientific and technological services relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files, namely, scientific research in the field of pharmaceuticals for pharmaceutical registration purposes; Pharmaceutical research services and consultancy in this field; Biomedical research services and consultancy in this field; Medical research and consultancy in this field; Chemistry and biology laboratories, namely, laboratory research services relating to pharmaceuticals; Laboratory services, namely, laboratory research services relating to pharmaceuticals; Development of pharmaceutical products and Ingredients; Information relating to medical and scientific research in the field of pharmaceutical preparations; Providing information on the results of clinical trials for pharmaceutical preparations; Quality control of products for others for the purpose of certification; Laboratory research services relating to pharmaceuticals and laboratory analysis services relating to pharmaceuticals; Research and design for the pharmaceutical industry, namely, pharmaceutical research and development; Research and development for others in the pharmaceutical and biotechnology fields; Drug discovery services; Quality control for others, namely, testing in the context of quality control; Conducting clinical trials for others for pharmaceutical preparations; Quality control for others, namely, conducting quality control of pharmaceutical preparations; providing information and data relating to pharmaceutical, biopharmaceutical and medical research and developments |
| INTERNATIONAL CLASS | 045 |
| DESCRIPTION TEXT | Legal services relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; legal services, namely, management of industrial property and copyright by means of license agreements; Licensing of intellectual property; legal services, namely, management of industrial property and copyright by issuing licenses to others; legal services, namely, legal extensions relating to the retention of intellectual property, for others; Legal advice in the field of intellectual property |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 035 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 040 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 045 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
| PRIORITY CLAIMED | SEC. 44(D) ON Benelux |
| APPLICATION NO. | 1400976 |
| APPLICATION FILING DATE | 08/21/2019 |
| FOREIGN REG NO. | 1400976 |
| FOREIGN REG DATE | 08/22/2019 |
| FOREIGN RNWL NUM | N/A |
| DATE OF FOREIGN RNWL | N/A |
| FOREIGN EXPIRATION | 08/21/2029 |
| FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 01/17/2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | 018 |
| 01/17/2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 017 |
| 01/17/2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 016 |
| 01/17/2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 015 |
| 01/17/2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 014 |
| 01/15/2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 013 |
| 01/17/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 012 |
| 01/17/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 011 |
| 01/15/2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 010 |
| 12/07/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 009 |
| 12/07/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 008 |
| 12/07/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 007 |
| 12/06/2019 | DOCK | D | ASSIGNED TO EXAMINER | 006 |
| 11/05/2019 | AMPX | O | APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 005 |
| 10/31/2019 | ALIE | A | ASSIGNED TO LIE | 004 |
| 10/25/2019 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | 003 |
| 09/16/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 09/07/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | E. Anthony Figg |
| CORRESPONDENCE ADDRESS | E. Anthony Figg ROTHWELL, FIGG, ERNST & MANBECK, PC 607 14TH STREET NW SUITE 800 WASHINGTON, DC 20005 |
| DOMESTIC REPRESENTATIVE | E. Anthony Figg |